Structures and binding studies of the complexes of phospholipase A2 with five inhibitors.

[1]  B. Cummings,et al.  Secretory phospholipase A2 enzymes as pharmacological targets for treatment of disease. , 2014, Biochemical pharmacology.

[2]  R. Stábeli,et al.  Snake Venom PLA2s Inhibitors Isolated from Brazilian Plants: Synthetic and Natural Molecules , 2013, BioMed research international.

[3]  Lawrence K. Lee,et al.  Selective Inhibition of Human Group IIA-secreted Phospholipase A2 (hGIIA) Signaling Reveals Arachidonic Acid Metabolism Is Associated with Colocalization of hGIIA to Vimentin in Rheumatoid Synoviocytes* , 2013, The Journal of Biological Chemistry.

[4]  E. Sabina,et al.  Ameliorative effect of p-coumaric acid, a common dietary phenol, on adjuvant-induced arthritis in rats , 2013, Rheumatology International.

[5]  H. Leaver,et al.  Therapeutic implications of disorders of cell death signalling: membranes, micro‐environment, and eicosanoid and docosanoid metabolism , 2012, British journal of pharmacology.

[6]  E. Dennis,et al.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. , 2011, Chemical reviews.

[7]  T. Mavromoustakos,et al.  The application of rational design on phospholipase A(2) inhibitors. , 2011, Current medicinal chemistry.

[8]  T. Singh,et al.  Identification of a novel and potent inhibitor of phospholipase A(2) in a medicinal plant: crystal structure at 1.93Å and Surface Plasmon Resonance analysis of phospholipase A(2) complexed with berberine. , 2011, Biochimica et biophysica acta.

[9]  Y. Miki,et al.  Recent progress in phospholipase A₂ research: from cells to animals to humans. , 2011, Progress in lipid research.

[10]  N. Pannu,et al.  REFMAC5 for the refinement of macromolecular crystal structures , 2011, Acta crystallographica. Section D, Biological crystallography.

[11]  Valerie B. O’Donnell,et al.  Molecular enzymology of lipoxygenases. , 2010, Archives of biochemistry and biophysics.

[12]  G. Salvador,et al.  Comparison between apo and complexed structures of bothropstoxin-I reveals the role of Lys122 and Ca(2+)-binding loop region for the catalytically inactive Lys49-PLA(2)s. , 2010, Journal of structural biology.

[13]  L. Lai,et al.  Finding multiple target optimal intervention in disease-related molecular network , 2008, Molecular systems biology.

[14]  K. Henrick,et al.  Inference of macromolecular assemblies from crystalline state. , 2007, Journal of molecular biology.

[15]  M. Perbandt,et al.  Crystal structures of the complexes of a group IIA phospholipase A2 with two natural anti‐inflammatory agents, anisic acid, and atropine reveal a similar mode of binding , 2006, Proteins.

[16]  Sujata Sharma,et al.  Specific binding of non-steroidal anti-inflammatory drugs (NSAIDs) to phospholipase A2: structure of the complex formed between phospholipase A2 and diclofenac at 2.7 A resolution. , 2006, Acta crystallographica. Section D, Biological crystallography.

[17]  T. Singh,et al.  Crystal structure of the complex of the secretory phospholipase A2 from Daboia russelli pulchella with an endogenic indole derivative, 2-carbamoylmethyl-5-propyl-octahydro-indol-7-yl-acetic acid at 1.8 A resolution. , 2005, Biochimica et biophysica acta.

[18]  Sharmistha Dey,et al.  Phospholipase A2 as a target protein for nonsteroidal anti-inflammatory drugs (NSAIDS): crystal structure of the complex formed between phospholipase A2 and oxyphenbutazone at 1.6 A resolution. , 2004, Biochemistry.

[19]  C. Betzel,et al.  Asp49 phospholipase A(2)-elaidoylamide complex: a new mode of inhibition. , 2004, Biochemical and biophysical research communications.

[20]  H. Isomoto,et al.  Ghrelin enhances gastric motility through direct stimulation of intrinsic neural pathways and capsaicin-sensitive afferent neurones in rats , 2004, Scandinavian journal of gastroenterology.

[21]  W. Ma,et al.  Cyclooxygenase 2 in infiltrating inflammatory cells in injured nerve is universally up-regulated following various types of peripheral nerve injury , 2003, Neuroscience.

[22]  Jennifer L. Martin,et al.  D‐Tyrosine as a Chiral Precusor to Potent Inhibitors of Human Nonpancreatic Secretory Phospholipase A2 (IIa) with Antiinflammatory Activity , 2003, Chembiochem : a European journal of chemical biology.

[23]  C. Betzel,et al.  Structural basis of phospholipase A2 inhibition for the synthesis of prostaglandins by the plant alkaloid aristolochic acid from a 1.7 A crystal structure. , 2002, Biochemistry.

[24]  C. Betzel,et al.  First structural evidence of a specific inhibition of phospholipase A2 by alpha-tocopherol (vitamin E) and its implications in inflammation: crystal structure of the complex formed between phospholipase A2 and alpha-tocopherol at 1.8 A resolution. , 2002, Journal of molecular biology.

[25]  C. Betzel,et al.  Regulation of catalytic function by molecular association: structure of phospholipase A2 from Daboia russelli pulchella (DPLA2) at 1.9 A resolution. , 2001, Acta crystallographica. Section D, Biological crystallography.

[26]  E. Hume,et al.  Phospholipase A(2) in rabbit tears: a host defense against Staphylococcus aureus. , 2001, Investigative ophthalmology & visual science.

[27]  D. Benhamou,et al.  Resveratrol decreases hyperalgesia induced by carrageenan in the rat hind paw. , 2001, Life sciences.

[28]  Makoto Murakami,et al.  Molecular Identification of Cytosolic Prostaglandin E2 Synthase That Is Functionally Coupled with Cyclooxygenase-1 in Immediate Prostaglandin E2Biosynthesis* , 2000, The Journal of Biological Chemistry.

[29]  J. J. Moreno.  Resveratrol modulates arachidonic acid release, prostaglandin synthesis, and 3T6 fibroblast growth. , 2000, The Journal of pharmacology and experimental therapeutics.

[30]  Y. Ohizumi,et al.  Structure-activity relationship of gramine derivatives in Ca(2+) release from sarcoplasmic reticulum. , 1999, European journal of pharmacology.

[31]  Anastassis Perrakis,et al.  Automated protein model building combined with iterative structure refinement , 1999, Nature Structural Biology.

[32]  M. Murakami,et al.  Functional Coupling Between Various Phospholipase A2s and Cyclooxygenases in Immediate and Delayed Prostanoid Biosynthetic Pathways* , 1999, The Journal of Biological Chemistry.

[33]  T. Evans,et al.  Cyclooxygenase-2 as a therapeutic target , 1998, Inflammation Research.

[34]  M. Moskowitz,et al.  Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2 , 1997, Nature.

[35]  J.-P. Wery,et al.  Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2 , 1995, Nature Structural Biology.

[36]  J. J. Rosa,et al.  Structures of free and inhibited human secretory phospholipase A2 from inflammatory exudate. , 1993, Science.

[37]  F. Frey,et al.  Glucocorticoid deficiency increases phospholipase A2 activity in rats. , 1993, The Journal of clinical investigation.

[38]  W. Smith.  Prostanoid biosynthesis and mechanisms of action. , 1992, The American journal of physiology.

[39]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[40]  H. Teraoka,et al.  Glucocorticoids suppress group II phospholipase A2 production by blocking mRNA synthesis and post-transcriptional expression. , 1990, Journal of Biological Chemistry.

[41]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .

[42]  Alexei Vagin,et al.  Molecular replacement with MOLREP. , 2010, Acta crystallographica. Section D, Biological crystallography.

[43]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[44]  Toshiyuki Shibata,et al.  Inhibitory effects of brown algal phlorotannins on secretory phospholipase A2s, lipoxygenases and cyclooxygenases , 2004, Journal of Applied Phycology.

[45]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[46]  L. Marnett,et al.  Prostaglandin and thromboxane biosynthesis. , 1991, Pharmacology & therapeutics.

[47]  R. Murphy,et al.  Incorporation of arachidonic acid into glycerophospholipids of a murine bone marrow derived mast cell. , 1990, Advances in prostaglandin, thromboxane, and leukotriene research.